Bluebird Bio Inc. (BLUE) stock trades up, “Sell” rating reiterated by Cantor Fitzgerald Analysts

Bluebird Bio Inc. (NASDAQ: BLUE) shares rose on Thursday Dec 1 with heavier trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Meanwhile, U.S. stocks opened with slight gains on Thursday.

The Dow Jones Industrial Average DJIA, +0.31% rose 38.22 points, or 0.2%, to 19,174, while the S&P 500 SPX, +0.01% added 2.1 points to 2,202, a rise of 0.1%.

The Nasdaq Composite Index COMP, -0.32% rose less than 1 point to 5,323, essentially unchanged on the day.
Bluebird Bio Inc. (NASDAQ: BLUE) had its Sell rating reiterated by equities researchers at Cantor Fitzgerald in a research note to investors. With a rating of Sell on the shares, the company has a 52-week high of $94.61. The one-year price target of $76.86 is above the opening price of $74.50, that has caused a number of other analysts to comment on the company recently. Typically, after analysts assign a “reiterated rating” report on a stock, they will later issue other revisions, such as a price target change.

Bluebird Bio Inc. (NASDAQ: BLUE) shares last traded at $72.75, which represents an increase of $12.40 or 20.55% from the previous closing price. Opening at $74.50, they varied from $72.60 and $76.75 throughout the day.

Bluebird Bio Inc. (NASDAQ: BLUE) currently has a market cap of 2.71B.

Bluebird Bio Inc. (NASDAQ: BLUE) Average Daily Trading Volume

The stock’s average daily volume is 1,371,750 shares out of a total float 34,944,000 and some 1,787,368 shares crossed the trading desk yesterday, higher than normal. Excessive volume aggregation by institutional investors may be in the near future as the combination of large gains in trading volume and price appreciation can be determining factors.

As with all potential breakouts, investors watch for volume to be at least 40%-50% greater than normal on the breakout to show that fund managers and other professional investors are jumping in.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Professional investors such as these have teams of analysts that research thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.

Bluebird Bio Inc. (NASDAQ: BLUE) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By identifying trends, moving averages allow investors to make those trends work in their favor and increase the number of successful trades.

Trades for Bluebird Bio Inc. (NASDAQ: BLUE) have ranged from $35.37 – 94.61, and the stock now has a 50-day MA of $55.97 and 200-day MA of $53.04. Today’s last price is 23.11%% below the 52 week high of $94.61.

Indeed, earnings growth is among the most crucial things to look at in regards to stock investing and, accordingly, investors identify companies that have been successful at growing their earnings at least 25% or more for the past 3 years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *